BioNTech/Pfizer brings forward 50 mn doses for EU to Q2 says von der Leyen
- il y a 3 ans
European Commission President Ursula von der Leyen announces
the EU will soon receive 50 million doses of the BioNTech/Pfizer vaccine, initially expected at the end of this year, as AstraZeneca and Johnson & John face setbacks over blood clot links.
the EU will soon receive 50 million doses of the BioNTech/Pfizer vaccine, initially expected at the end of this year, as AstraZeneca and Johnson & John face setbacks over blood clot links.